Impact of a Mobile Telerehabilitation Solution on Metabolic Health Outcomes and Rehabilitation Adherence in Patients With Obesity: Randomized Controlled Trial.
mHealth
mobile phone
obesity
rehabilitation
telerehabilitation
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
06 12 2021
06 12 2021
Historique:
received:
25
02
2021
accepted:
17
09
2021
revised:
10
06
2021
entrez:
7
12
2021
pubmed:
8
12
2021
medline:
2
2
2022
Statut:
epublish
Résumé
Obesity is a major public health issue. Combining exercise training, nutrition, and therapeutic education in metabolic rehabilitation (MR) is recommended for obesity management. However, evidence from randomized controlled studies is lacking. In addition, MR is associated with poor patient adherence. Mobile health devices improve access to MR components. The aim of this study is to compare the changes in body composition, anthropometric parameters, exercise capacity, and quality of life (QOL) within 12 weeks of patients in the telerehabilitation (TR) program to those of usual care patients with obesity. This was a parallel-design randomized controlled study. In total, 50 patients with obesity (BMI>30 kg/m²) were included in a TR group (TRG) or a usual care group (UCG) for 12 weeks. Patients underwent biometric impedance analyses, metabolic exercise tests, actimetry, and QOL and satisfaction questionnaires. The primary outcome was the change in fat mass at 12 weeks from baseline. Secondary outcomes were changes in body weight, metabolic parameters, exercise capacity, QOL, patients' adhesion, and satisfaction. A total of 49 patients completed the study. No significant group × time interaction was found for fat mass (TRG: mean 1.7 kg, SD 2.6 kg; UCG: mean 1.2 kg, SD 2.4 kg; P=.48). Compared with the UCG, TRG patients tended to significantly improve their waist to hip ratios (TRG: -0.01 kg, SD 0.04; UCG: +0.01 kg, SD 0.06; P=.07) and improved QOL physical impact (TRG: +21.8, SD 43.6; UCG: -1.2, SD 15.4; P=.005). Significant time effects were observed for body composition, 6-minute walk test distance, exercise metabolism, sedentary time, and QOL. Adherence (95%) and satisfaction in the TRG were good. In adults with obesity, the TR program was not superior to usual care for improving body composition. However, TR was able to deliver full multidisciplinary rehabilitation to patients with obesity and improve some health outcomes. Given the patients' adherence and satisfaction, pragmatic programs should consider mobile health devices to improve access to MR. Further studies are warranted to further establish the benefits that TR has over usual care. ClinicalTrials.gov NCT03396666; http://clinicaltrials.gov/ct2/show/NCT03396666.
Sections du résumé
BACKGROUND
Obesity is a major public health issue. Combining exercise training, nutrition, and therapeutic education in metabolic rehabilitation (MR) is recommended for obesity management. However, evidence from randomized controlled studies is lacking. In addition, MR is associated with poor patient adherence. Mobile health devices improve access to MR components.
OBJECTIVE
The aim of this study is to compare the changes in body composition, anthropometric parameters, exercise capacity, and quality of life (QOL) within 12 weeks of patients in the telerehabilitation (TR) program to those of usual care patients with obesity.
METHODS
This was a parallel-design randomized controlled study. In total, 50 patients with obesity (BMI>30 kg/m²) were included in a TR group (TRG) or a usual care group (UCG) for 12 weeks. Patients underwent biometric impedance analyses, metabolic exercise tests, actimetry, and QOL and satisfaction questionnaires. The primary outcome was the change in fat mass at 12 weeks from baseline. Secondary outcomes were changes in body weight, metabolic parameters, exercise capacity, QOL, patients' adhesion, and satisfaction.
RESULTS
A total of 49 patients completed the study. No significant group × time interaction was found for fat mass (TRG: mean 1.7 kg, SD 2.6 kg; UCG: mean 1.2 kg, SD 2.4 kg; P=.48). Compared with the UCG, TRG patients tended to significantly improve their waist to hip ratios (TRG: -0.01 kg, SD 0.04; UCG: +0.01 kg, SD 0.06; P=.07) and improved QOL physical impact (TRG: +21.8, SD 43.6; UCG: -1.2, SD 15.4; P=.005). Significant time effects were observed for body composition, 6-minute walk test distance, exercise metabolism, sedentary time, and QOL. Adherence (95%) and satisfaction in the TRG were good.
CONCLUSIONS
In adults with obesity, the TR program was not superior to usual care for improving body composition. However, TR was able to deliver full multidisciplinary rehabilitation to patients with obesity and improve some health outcomes. Given the patients' adherence and satisfaction, pragmatic programs should consider mobile health devices to improve access to MR. Further studies are warranted to further establish the benefits that TR has over usual care.
TRIAL REGISTRATION
ClinicalTrials.gov NCT03396666; http://clinicaltrials.gov/ct2/show/NCT03396666.
Identifiants
pubmed: 34874887
pii: v9i12e28242
doi: 10.2196/28242
pmc: PMC8691412
doi:
Banques de données
ClinicalTrials.gov
['NCT03396666']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e28242Informations de copyright
©François Bughin, Gaspard Bui, Bronia Ayoub, Leo Blervaque, Didier Saey, Antoine Avignon, Jean Frédéric Brun, Nicolas Molinari, Pascal Pomies, Jacques Mercier, Fares Gouzi, Maurice Hayot. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 06.12.2021.
Références
Adv Nutr. 2017 May 15;8(3):449-462
pubmed: 28507010
J Ren Nutr. 2015 Nov;25(6):472-9
pubmed: 26143293
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
J Diabetes Res. 2015;2015:729567
pubmed: 25950007
Arthritis Rheum. 2001 Aug;45(4):384-91
pubmed: 11501727
Med Eng Phys. 2008 Dec;30(10):1257-69
pubmed: 18676172
Clin Obes. 2017 Oct;7(5):260-272
pubmed: 28695579
J Clin Endocrinol Metab. 1982 Feb;54(2):254-60
pubmed: 7033275
Scand J Med Sci Sports. 2019 Jul;29(7):910-921
pubmed: 30929281
JMIR Mhealth Uhealth. 2020 Nov 27;8(11):e17957
pubmed: 33245286
J Diabetes Res. 2020 Aug 1;2020:9327910
pubmed: 32832564
Circulation. 2012 Sep 4;126(10):1301-13
pubmed: 22949540
J Telemed Telecare. 2019 Feb;25(2):67-79
pubmed: 29117794
Obes Rev. 2016 Dec;17(12):1226-1244
pubmed: 27743411
JMIR Mhealth Uhealth. 2021 Mar 3;9(3):e21061
pubmed: 33656444
JMIR Mhealth Uhealth. 2020 Apr 28;8(4):e15400
pubmed: 32343253
Chest. 2014 Aug;146(2):318-327
pubmed: 24603844
Clin Nutr. 2011 Oct;30(5):610-5
pubmed: 21555168
Med Care. 1994 Jan;32(1):40-66
pubmed: 8277801
Endocrinology. 2014 May;155(5):1573-88
pubmed: 24605831
PLoS One. 2015 Apr 01;10(4):e0119017
pubmed: 25830342
JAMA. 2019 Apr 9;321(14):1349-1350
pubmed: 30896727
Obes Res. 2004 May;12(5):789-98
pubmed: 15166299
Nutrients. 2020 Jul 26;12(8):
pubmed: 32722652
Am J Physiol. 1991 Aug;261(2 Pt 1):E159-67
pubmed: 1872379
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Physiol Behav. 2019 Oct 15;210:112549
pubmed: 31082444
Eur J Health Econ. 2015 Dec;16(9):957-67
pubmed: 25381038
Am J Respir Crit Care Med. 2020 Mar 15;201(6):718-727
pubmed: 31918559
J Nutr Metab. 2012;2012:285395
pubmed: 22928092
J Nutr Metab. 2014;2014:421423
pubmed: 25525513
J Med Internet Res. 2019 Apr 15;21(4):e13281
pubmed: 30985284
Am J Cardiol. 1994 Mar 1;73(7):460-8
pubmed: 8141087
Healthc Inform Res. 2019 Jan;25(1):12-26
pubmed: 30788177
J Med Internet Res. 2018 Oct 26;20(10):e10867
pubmed: 30368437
Ann Intern Med. 2015 Mar 3;162(5):325-34
pubmed: 25732273
Clin Obes. 2014 Aug;4(4):220-7
pubmed: 25826793
J Hum Nutr Diet. 2019 Jun;32(3):329-337
pubmed: 30565772
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2985-3023
pubmed: 24239920
Sci Rep. 2019 Mar 5;9(1):3450
pubmed: 30837600
Obes Facts. 2019;12(2):199-210
pubmed: 30928989
Disabil Rehabil. 2018 Jan;40(2):125-134
pubmed: 27848247
JAMA. 2005 Jan 5;293(1):43-53
pubmed: 15632335
Ther Umsch. 2019 Sep;76(3):117-121
pubmed: 31498046
J Appl Physiol (1985). 1994 Jun;76(6):2253-61
pubmed: 7928844
Proc Nutr Soc. 2000 Aug;59(3):337-45
pubmed: 10997649
J Multidiscip Healthc. 2016 Mar 07;9:103-9
pubmed: 27022273
Br J Gen Pract. 2008 Aug;58(553):548-54
pubmed: 18682018
Clin Obes. 2019 Dec;9(6):e12337
pubmed: 31475476
BMC Geriatr. 2020 May 12;20(1):173
pubmed: 32398024
Am J Med. 2013 Mar;126(3):236-42, 242.e1-2
pubmed: 23410564
Arthritis Rheum. 2000 Jul;43(7):1478-87
pubmed: 10902749
Diabetes Metab. 2008 Apr;34(2):162-8
pubmed: 18396088
Diabetes Metab. 2001 Sep;27(4 Pt 1):466-74
pubmed: 11547220
Age Ageing. 2018 Jan 1;47(1):82-88
pubmed: 28985325
J Med Internet Res. 2011 Dec 31;13(4):e126
pubmed: 22209829
Lancet. 2017 Dec 16;390(10113):2627-2642
pubmed: 29029897
Prim Care Diabetes. 2019 Dec;13(6):542-548
pubmed: 31014938
Am J Respir Crit Care Med. 2015 Dec 1;192(11):1373-86
pubmed: 26623686
Med Sci Sports Exerc. 2001 Jun;33(6 Suppl):S521-7; discussion S528-9
pubmed: 11427779
Clin Obes. 2015 Oct;5(5):237-44
pubmed: 26222044